Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF
Authors
Keywords
-
Journal
ULTRASOUND IN OBSTETRICS & GYNECOLOGY
Volume 49, Issue 2, Pages 201-208
Publisher
Wiley
Online
2016-09-27
DOI
10.1002/uog.17307
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation
- (2017) N. O'Gorman et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30–34 weeks’ gestation
- (2016) Andreas Tsiakkas et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation
- (2016) Neil O’Gorman et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
- (2016) Harald Zeisler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maternal serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia
- (2016) A. Tsiakkas et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Maternal serum soluble fms-like tyrosine kinase-1 at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia
- (2016) A. Tsiakkas et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Competing risks model in screening for preeclampsia by maternal characteristics and medical history
- (2015) David Wright et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history
- (2015) A. Tsiakkas et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history
- (2015) A. Tsiakkas et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation
- (2014) Jonathan Lai et al. FETAL DIAGNOSIS AND THERAPY
- Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19–31 weeks of gestation
- (2013) Akihide Ohkuchi et al. HYPERTENSION RESEARCH
- Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia
- (2012) Sarosh Rana et al. CIRCULATION
- A Competing Risks Model in Early Screening for Preeclampsia
- (2012) David Wright et al. FETAL DIAGNOSIS AND THERAPY
- Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia
- (2012) Tinnakorn Chaiworapongsa et al. Journal of Maternal-Fetal & Neonatal Medicine
- The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
- (2011) Stefan Verlohren et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Turning the Pyramid of Prenatal Care
- (2011) Kypros H. Nicolaides FETAL DIAGNOSIS AND THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now